Advancing Human Health & Performance
What if wearables could change lives? Orpyx® foot pressure measurement technologies includes wearable sensors used to improve human health and advance sports performance.
Limb loss isn’t inevitable. Help prevent diabetic foot ulcers and track progress. Get your feet back on track with the SurroSense Rx system.
Accurate, efficient, and real-time measurement of foot and plantar pressure analysis. 100% mobile, durable and reusable, no tether, computer or lab required.
Manchester Metropolitan University Receives Award at the Diabetic Foot Study Group Scientific Meeting
The oral presentation titled “Novel Plantar Pressure-Sensing Smart Insoles Reduce Foot Ulcer Incidence in ‘High Risk’ Diabetic Patients: A Longitudinal Study” was awarded the prestigious Paul Wilson Brand Repetitive Stress Award at the 15th annual meeting of the Diabetic Foot Study Group of the EASD (European Association for the Study of Diabetes), held in Berlin, Germany September 28 – 30, 2018.read more
Results from a randomized clinical trial ran by Manchester Metropolitan University showed the SurroSense Rx provided a 71 per cent reduction in foot ulcers over an 18-month long study. Manchester Metropolitan University will be presenting their findings at EASD 2018 (European Association for the Study of Diabetes) at the Messe Berlin Exhibition Halls in Berlin-Charlottenburg, Germany on October 2, 2018.read more
Orpyx Medical Technologies Inc. announced today that the United States Patent and Trademark Office has awarded Orpyx an important patent related to the company’s foundation technology. The “Peripheral Sensory and Supersensory Replacement System” patent covers key inventions used in both Orpyx’s SurroSense Rx® product and future products, such as SurroGait Rx, in the United States.read more
U.S. Patent No. 10,004,428 - June 2018
U.S. Patent No. 9,778,131 B2 - October 2017
U.S. Patent No. D740,950 S - October 2015
Australia Patent No. 2011320072 - May 2016
Japan Patent No. 6004444 - October 2016
New Zealand Patent No. 611197 - November 2015